SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form CORRESP - Correspondence:
SEC Accession No. 0001104659-20-103455
Filing Date
2020-09-09
Accepted
2020-09-09 16:15:54
Documents
1

Document Format Files

Seq Description Document Type Size
1 filename1.htm CORRESP 9259
  Complete submission text file 0001104659-20-103455.txt   10248
Mailing Address 1000 CONTINENTAL DRIVE SUITE 600 KING OF PRUSSIA PA 19406
Business Address 56 FITZWILLIAM SQUARE DUBLIN L2 2 (610) 816-6640
Nabriva Therapeutics plc (Filer) CIK: 0001641640 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: CORRESP
SIC: 2834 Pharmaceutical Preparations